New PET scan spots hidden prostate cancer when standard tests fail

NCT ID NCT05407311

Completed Diagnosis Sponsor: Clarity Pharmaceuticals Ltd Source: ClinicalTrials.gov ↗

First seen Nov 17, 2025 · Last updated May 11, 2026 · Updated 23 times

Summary

This study tested a new type of PET scan (64Cu-SAR-BBN) to see if it can safely and accurately find prostate cancer that has returned in 53 men whose standard PSMA scans were negative. The goal was to improve detection of cancer recurrence after initial treatment. The study is complete, and results will show how well this scan works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bamf Health, Inc

Grand Rapids, Michigan, 49503, United States
Biogenix Molecular

Miami, Florida, 33165, United States
Carolina Urologic Research Center

Myrtle Beach, South Carolina, 29572, United States
GU Research Network

Omaha, Nebraska, 68130, United States
St Louis University Hospital

St Louis, Missouri, 63104, United States
Stanford University

Stanford, California, 94305, United States
Tower Urology

Los Angeles, California, 90048, United States
Urology San Antonio

San Antonio, Texas, 78258, United States

Conditions

Explore the condition pages connected to this study.

BIOCHEMICAL RECURRENCE OF MALIGNANT NEOPLASM OF PROSTATE